IL-23 receptor antagonists and uses thereof

Details for Australian Patent Application No. 2008273814 (hide)

Owner Valorisation HSJ, Societe en Commandite

Inventors Lubell, William D.; Quiniou, Christiane; Chemtob, Sylvain

Agent Pizzeys

Pub. Number AU-A-2008273814

PCT Pub. Number WO2009/007849

Priority 60/958,660 06.07.07 US

Filing date 7 July 2008

Wipo publication date 15 January 2009

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2009/007849 Priority application(s): WO2009/007849

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008273815-Hybrid stent having a fiber or wire backbone

2008273813-Bioactive peptides and method of using same